Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, November 2000, p. 3092-3096, Vol. 44, No. 11
Critical Care Medicine Department, Warren Grant
Magnuson Clinical Center, National Institutes of Health, Bethesda,
Maryland
Received 23 May 2000/Returned for modification 27 June
2000/Accepted 1 August 2000
Dihydrofolate reductase (DHFR) is the target of trimethoprim (TMP),
which has been widely used in combination with sulfa drugs for
treatment and prophylaxis of Pneumocystis carinii
pneumonia. While the rat-derived P. carinii DHFR has been
well characterized, kinetic studies of human-derived P. carinii DHFR, which differs from rat-derived P. carinii DHFR by 38% in amino acid sequence, have not been
reported to date. Here we report on the expression and kinetic
characterization of the recombinant human-derived P. carinii DHFR. The 618-bp coding sequence of the human-derived P. carinii DHFR gene was expressed in Escherichia
coli. As determined by sodium dodecyl sulfate-polyacrylamide gel
eletrophoresis, the purified enzyme had a molecular mass of 25 kDa,
consistent with that predicted from the DNA sequence. Kinetic analysis
showed that the Km values for dihydrofolate and
NADPH were 2.7 ± 0.3 and 14.0 ± 4.3 µM, respectively, which are
similar to those reported for rat-derived P. carinii DHFR.
Inhibition studies revealed that both TMP and pyrimethamine were
poor inhibitors of human-derived P. carinii DHFR, with
Ki values of 0.28 ± 0.08 and
0.065 ± 0.005 µM, respectively, while trimetrexate and
methotrexate were potent inhibitors, with Ki
values of 0.23 ± 0.03 and 0.016 ± 0.004 nM, respectively. The
availability of purified recombinant enzyme in large quantities should
facilitate the identification of antifolate inhibitors with greater
potency and higher selectivity for human-derived P. carinii DHFR.
0066-4804/00/$04.00+0
Expression and Characterization of Recombinant Human-Derived
Pneumocystis carinii Dihydrofolate Reductase
*
Corresponding author. Mailing address: Building 10, Room 7D43, National Institutes of Health, 10 Center Dr. MSC 1662, Bethesda, MD 20892-1662. Phone: (301) 496-9907. Fax: (301)
402-1213. E-mail: jkovacs{at}nih.gov.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»